Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1975 of 3173 entries
View as:

A Study to Determine Whether an Oral Drops Formulation of Triazolam is Bioequivalent to a Tablet Formulation in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01421043 Org: User:
Start: 09/30/11 End: 10/31/11 Due: 10/31/12

13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants.

Phase: N/A Priority: Normal
NCT ID: NCT01964716 Org: User:
Start: 01/31/14 End: 09/30/14 Due: 09/30/15

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

Phase: N/A Priority: Normal
NCT ID: NCT00161772 Org: User:
Start: 03/31/02 End: 08/31/02 Due: 08/31/03

Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00136916 Org: User:
Start: 06/30/02 End: 12/31/08 Due: 12/31/09

A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Abusers

Phase: N/A Priority: Normal
NCT ID: NCT01746901 Org: User:
Start: 02/28/13 End: 08/09/13 Due: 08/09/14

Growth Retardation In Children With Special Pathological Conditions Or Disease

Phase: N/A Priority: Normal
NCT ID: NCT00163215 Org: User:
Start: 01/31/05 End: 10/31/11 Due: 10/31/12

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

Phase: N/A Priority: Normal
NCT ID: NCT04535167 Org: User:
Start: 09/09/20 End: 06/07/21 Due: 06/07/22

Voriconazole For Chronic Bronchopulmonary Aspergillosis

Phase: N/A Priority: Normal
NCT ID: NCT00159822 Org: User:
Start: 07/31/05 End: 12/31/08 Due: 12/31/09

A Study of ARRY-502 in Patients With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01561690 Org: User:
Start: 04/02/12 End: 06/10/13 Due: 06/10/14

Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.

Phase: N/A Priority: Normal
NCT ID: NCT04033991 Org: User:
Start: 09/27/19 End: 12/18/20 Due: 12/18/21

A Study to Learn How Different Amounts of the Study Medicine Called PF-07941944 Are Tolerated in the Body of Healthy Adults.

Phase: N/A Priority: Normal
NCT ID: NCT06920498 Org: User:
Start: 12/03/24 End: 04/04/25 Due: 04/04/26

A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01429740 Org: User:
Start: 08/31/11 End: 12/31/11 Due: 12/31/12

A Study Of PF-03732010 In Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00557505 Org: User:
Start: 12/31/07 End: 02/28/11 Due: 02/28/12

A Low Interventional Study to Monitor Activity Using Wearable Sensors in Duchenne Muscular Dystrophy

Phase: N/A Priority: Normal
NCT ID: NCT04254172 Org: User:
Start: 02/19/20 End: 08/19/20 Due: 08/19/21

Genotropin Study Assessing Use of Injection Pen

Phase: N/A Priority: Normal
NCT ID: NCT00965484 Org: User:
Start: 10/31/09 End: 01/31/10 Due: 01/31/11

Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia

Phase: N/A Priority: Normal
NCT ID: NCT02956967 Org: User:
Start: 09/23/15 End: 12/12/16 Due: 12/12/17

The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01033396 Org: User:
Start: 01/31/10 End: 05/31/10 Due: 05/31/11

Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00991016 Org: User:
Start: 10/31/09 End: 08/31/10 Due: 08/31/11

A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)

Phase: N/A Priority: Normal
NCT ID: NCT02215252 Org: User:
Start: 11/10/14 End: 09/28/15 Due: 09/28/16

Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00031278 Org: User:
Start: 10/31/01 End: 06/30/03 Due: 06/30/04

Actual Use and Compliance Study Of Ibuprofen 600 Mg Immediate Release/Extended Release Tablets In At-Risk OTC Consumers

Phase: N/A Priority: Normal
NCT ID: NCT03722238 Org: User:
Start: 12/27/18 End: 10/28/19 Due: 10/28/20

Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.

Phase: N/A Priority: Normal
NCT ID: NCT05035212 Org: User:
Start: 08/31/21 End: 06/12/26 Due: 06/12/27

A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN

Phase: N/A Priority: Normal
NCT ID: NCT04032093 Org: User:
Start: 08/07/19 End: 09/30/21 Due: 09/30/22

Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice

Phase: N/A Priority: Normal
NCT ID: NCT01147874 Org: User:
Start: 08/31/10 End: 07/31/11 Due: 07/31/12

A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.

Phase: N/A Priority: Normal
NCT ID: NCT01436513 Org: User:
Start: 10/31/11 End: 03/31/12 Due: 03/31/13